Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
The phase III REFRESH study has been approved by the regulatory authorities and ethics committees in South...
Firibastat is as efficient as the current standard of care (ramipril) in preventing the degradation of the left...
PARIS, July 08, 2021 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a...
PARIS, July 05, 2021 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC...
PARIS, May 19, 2021 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a...
€1.5 million guaranteed by the French government (PGE) and granted by BNP bank €1.5 million innovation and...
PARIS, April 21, 2021 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a...
PARIS and NEW YORK, April 20, 2021 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971...
Recruitment of first subjects for Phase III trial in difficult-to-treat and resistant arterial hypertension...
PARIS and NEW YORK, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971...
LONDON, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Quantum Genomics (ALQGC) has announced that the results of its...
PARIS and NEW YORK, March 24, 2016 (GLOBE NEWSWIRE) -- Quantum Genomics (Alternext - FR0011648971...
Establishes U.S. Clinical Advisory BoardAnnounces Plans to Open U.S. Office MASSY, France, Feb. 03, 2016...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관
광고 없는 경험을 위해 가입하세요
지금 사용해 보세요
광고 유지